The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Mass Immunization

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Mass Immunization


Psychiatry related information on Mass Immunization


High impact information on Mass Immunization

  • A mass immunization campaign with a Urabe-containing measles-mumps-rubella vaccine was carried out in 1997 in the city of Salvador, northeastern Brazil, with a target population of children aged 1-11 years [6].
  • The International Tuberculosis Campaign: a pioneering venture in mass vaccination and research [7].
  • For this purpose, paired sera were collected from a cohort of children before and after a mass vaccination with OPV in Morocco in 1987 [8].
  • Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine [9].
  • Since the carboxyamidation reaction can be easily monitored and the carboxyamidated Tat retained the whole immunogenicity of the native molecule, it should be the toxoid of choice for mass immunization [10].

Associations of Mass Immunization with chemical compounds


  1. Antibodies to Haemophilus influenzae serotype b in the Netherlands a few years after the introduction of routine vaccination. van Den Hof, S., de Melker, H.E., Berbers, G.A., van Der Kraak, P.H., Spaendonck, M.A. Clin. Infect. Dis. (2001) [Pubmed]
  2. Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C. Fernández, S., Arreaza, L., Santiago, I., Malvar, A., Berrón, S., Vazquez, J.A., Hervada, X. J. Med. Microbiol. (2003) [Pubmed]
  3. A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trial. Yang, J., Acosta, C.J., Si, G.A., Zeng, J., Li, C.Y., Liang, D.B., Ochiai, R.L., Page, A.L., Danovaro-Holliday, M.C., Zhang, J., Zhou, B.D., Liao, H.Z., Wang, M.L., Tan, D.M., Tang, Z.Z., Gong, J., Park, J.K., Ali, M., Ivanoff, B., Liang, G.C., Yang, H.H., Pang, T., Xu, Z.Y., Donner, A., Galindo, C.M., Dong, B.Q., Clemens, J.D. BMC public health [electronic resource]. (2005) [Pubmed]
  4. 1987 yellow fever epidemics in Oyo State, Nigeria: a survey for yellow fever virus haemagglutination inhibiting antibody in residents of two communities before and after the epidemics. Olaleye, O.D., Omilabu, S.A., Faseru, O., Fagbami, A.H. Virologie. (1988) [Pubmed]
  5. MMR mass vaccination campaigns, vaccine-related adverse events, and the limits of the decision making process, in Brazil. Cunha, S.C., Dourado, I. Health policy (Amsterdam, Netherlands) (2004) [Pubmed]
  6. Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs. Dourado, I., Cunha, S., Teixeira, M.G., Farrington, C.P., Melo, A., Lucena, R., Barreto, M.L. Am. J. Epidemiol. (2000) [Pubmed]
  7. The International Tuberculosis Campaign: a pioneering venture in mass vaccination and research. Comstock, G.W. Clin. Infect. Dis. (1994) [Pubmed]
  8. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes. Richardson, G., Linkins, R.W., Eames, M.A., Wood, D.J., Campbell, P.J., Ankers, E., Deniel, M., Kabbaj, A., Magrath, D.I., Minor, P.D. Bull. World Health Organ. (1995) [Pubmed]
  9. Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine. Pereiró, I., Díez-Domingo, J., Morant, A., Gimeno, C., Lerma, M., San-Martín, M., González, A. Scand. J. Infect. Dis. (2001) [Pubmed]
  10. Procedures for preparing biologically inactive, but immunogenic HIV-1 Tat protein (Tat toxoid) for human use. Le Buanec, H., Bizzini, B. Biomed. Pharmacother. (2000) [Pubmed]
  11. Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain. Salleras, L., Domínguez, A., Cardeñosa, N. Vaccine (2003) [Pubmed]
WikiGenes - Universities